As a result, the levels of IL-18 and IL-1β were significantly reduced, and the protein expressions of NLRP3, gasdermin D, caspase 1, and ASC were also significantly decreased after PSG treatment, suggesting the good suppression of PSG on pyroptosis in treating SLI of the IBD mouse model. The gene discussed is IL18; the disease is inflammatory bowel disease.